PATENT CLAIM ANALYSIS

Application Number: 16135608
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "009700"]

Abstract:
The present invention relates, rider alia, to a method comprising administering to a subject having high output shock and undergoing treatment with a catecholamine at a dose equivalent to at least about 0.2 mcg/kg/min of norepinephrine a dose of angiotensin II which is effective to raise the blood pressure of the subject to a mean arterial pressure (MAP) of about 65 mm Hg or above, and which is effective to reduce the dose of the catecholamine required to maintain a MAP of about 65 mm Hg to the equivalent of about 0.05-0.2 mcg/kg/min norepinephrine or less, or to the equivalent of about 0.05 mcg/kg/min norepinephrine or less.

Claim (Index 54):
A method of achieving target mean arterial pressure (MAP) of at least about 65 mmHg in a human patient experiencing acute kidney injury, comprising administering angiotensin II to the patient at an initial rate of about 0.25 to 10 ng/kg/min and titrating the rate up or down.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15909617', '14941301', '14575127', '15870139', '16057366']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7136638783197132
- 35 USC 102 Novelty (BERT): 0.5397842633816264
- Combined Prediction Score: 0.6962759168259045
- Mean Citation Score: 319.163228
- Max Citation Score: 366.00192
- Similarity Product: 282.4342664103698

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test